Protective effects of arbutin against doxorubicin-induced cardiac damage.
Oguzhan BirdalIrmak Ferah OkkayUfuk OkkayCemil BayramBehzad MokthareMuhammed Sait ErtugrulAhmet HacimuftuogluEmrah AksakalYavuzer KozaMehmet SaygiHuseyin SenocakPublished in: Molecular biology reports (2024)
The study suggests that arbutin has the potential to be used to mitigate doxorubicin-induced cardiotoxicity in cancer patients.